Skip to main content
Research
  1. Queen Mary University of London
  2. Research
  3. Publications

Publications: Mr Thomas Moseley

Back to Search
Arokiasamy S, Balderstone MJM, Shaik F, Cristante E, Moseley TC, Madoo A, Rizzi M, Bainbridge JW et al. ( 2024 ) . QM107, a novel CD148 (RTP Type J) activating peptide therapy for treating neovascular age‐related macular degeneration . British Journal of Pharmacology vol. 182 , ( 4 ) 951 - 968 .